Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL38
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $98,274.72 by the Defense Logistics Agency on August 26, 2025. The delivery order calls for the supply of Keytruda 100 mg/4 ml vials, an oncology immunotherapy medication, with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace while leveraging its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The contract demonstrates DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, having consistently secured delivery orders for branded and generic prescription drugs, biologics, and specialty medical consumables to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDL38?
SPE2DB25FDL38 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FDL38 worth?
The government has obligated $98,275 on SPE2DB25FDL38.
Is contract SPE2DB25FDL38 an order under another contract?
Yes. SPE2DB25FDL38 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL38 competed?
The extent of competition for SPE2DB25FDL38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award